Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients | Zendy

AI Assistant Blog Pricing

Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.